Insights Into MetLife (MET) Q3: Wall Street Projections for Key Metrics
Werte in diesem Artikel
Wall Street analysts expect MetLife (MET) to post quarterly earnings of $2.33 per share in its upcoming report, which indicates a year-over-year increase of 20.7%. Revenues are expected to be $18.84 billion, up 7% from the year-ago quarter.Over the last 30 days, there has been an upward revision of 0.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.Bearing this in mind, let's now explore the average estimates of specific MetLife metrics that are commonly monitored and projected by Wall Street analysts.The consensus estimate for 'Revenue- Premiums' stands at $11.41 billion. The estimate suggests a change of +7.2% year over year.The average prediction of analysts places 'Revenue- Other Revenues' at $653.32 million. The estimate indicates a change of +0.8% from the prior-year quarter.Based on the collective assessment of analysts, 'Revenue- Universal life and investment-type product policy fees' should arrive at $1.31 billion. The estimate indicates a year-over-year change of +6.5%.The consensus among analysts is that 'Revenue- Net investment income' will reach $5.47 billion. The estimate indicates a year-over-year change of +4.7%.It is projected by analysts that the 'Total Adjusted Revenue- Latin America' will reach $2.09 billion. The estimate indicates a year-over-year change of +8.4%.Analysts' assessment points toward 'Adjusted Revenue- Corporate & other- Net investment income' reaching $83.06 million. The estimate points to a change of -13.5% from the year-ago quarter.Analysts forecast 'Total Adjusted Revenue- EMEA' to reach $773.03 million. The estimate points to a change of +8.9% from the year-ago quarter.The combined assessment of analysts suggests that 'Total Adjusted Revenue- Asia' will likely reach $3.08 billion. The estimate suggests a change of +8.5% year over year.Analysts expect 'Adjusted Revenue- Asia- Net investment income' to come in at $1.31 billion. The estimate indicates a change of +15.5% from the prior-year quarter.According to the collective judgment of analysts, 'Adjusted Revenue- EMEA- Net investment income' should come in at $62.02 million. The estimate indicates a year-over-year change of +12.8%.Analysts predict that the 'Adjusted Revenue- Latin America- Net investment income' will reach $442.90 million. The estimate points to a change of +1.8% from the year-ago quarter.The collective assessment of analysts points to an estimated 'Adjusted Revenue- Asia- Other Revenues' of $20.48 million. The estimate suggests a change of +13.8% year over year. View all Key Company Metrics for MetLife here>>> Shares of MetLife have demonstrated returns of -2.7% over the past month compared to the Zacks S&P 500 composite's +2.1% change. With a Zacks Rank #3 (Hold), MET is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf MetLife
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu MetLife Inc.
Analysen zu MetLife Inc.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.01.2018 | MetLife Hold | Deutsche Bank AG | |
| 03.11.2017 | MetLife Outperform | RBC Capital Markets | |
| 25.05.2017 | MetLife Outperform | FBR & Co. | |
| 09.12.2016 | MetLife Hold | Standpoint Research | |
| 28.11.2016 | MetLife Mkt Perform | FBR & Co. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.2017 | MetLife Outperform | RBC Capital Markets | |
| 25.05.2017 | MetLife Outperform | FBR & Co. | |
| 05.05.2016 | MetLife Outperform | RBC Capital Markets | |
| 31.07.2015 | MetLife Buy | Deutsche Bank AG | |
| 22.06.2015 | MetLife Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.01.2018 | MetLife Hold | Deutsche Bank AG | |
| 09.12.2016 | MetLife Hold | Standpoint Research | |
| 28.11.2016 | MetLife Mkt Perform | FBR & Co. | |
| 13.07.2016 | MetLife Hold | Deutsche Bank AG | |
| 15.03.2016 | MetLife Neutral | UBS AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.12.2006 | Update MetLife Inc.: Underperform | Friedman, Billings Ramsey & Co | |
| 14.09.2005 | MetLife Downgrade | Deutsche Securities | |
| 14.09.2005 | Update MetLife Inc.: Sell | Deutsche Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen